Bluejay Diagnostics (BJDX) Stock Rockets on Expanded Partnership: A Game-Changer for Sepsis Testing?
Listen up, folks—markets don't get much hotter than this right now. As of this writing, on October 9, 2025, Bluejay Diagnostics (BJDX) is lighting up the board with an eye-popping surge of nearly 87%, pushing shares to around $3.49. That's the kind of move that has...